Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
ARK.V 0SGD.V 0.46AEM.TO -4.78MEQ.TO -1.05TRI.TO 2.93KKR 1.49CGI.TO -0.09KINS -0.06
Daily Stock Opinions and Ratings
Stockchase Opinions

Jean-Francois TardifFuturemed HealthcareFMD.TOTOP PICKFeb 15, 2006

They are a distributor so they don't need to have a lot of assets. All the earnings are free cash flow which allows a nice distribution every month. Current yield is around 9%. Have been growing every year.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$10.34

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist
Track your Stocks in your Watch List

You might be interested:

PAST TOP PICK

Futuremed Healthcare(FMD.TO)

Jun 17, 2011
(A Top Pick July 7/10. Down 10.07%.) Sold his holdings.
Photo of Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$7.74

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Futuremed Healthcare(FMD.TO)

Apr 07, 2011
(A Top Pick Dec 16/09. Down 14.43%.) Supplies to seniors’ homes. Pays a yield of 9%. Missed their growth objectives so he sold his holdings.
Photo of Jamie HorvatJamie Horvat
No
Unlock Rating
$6.85

Stock price when the opinion was issued

biotechnologypharmaceutical
WATCH

Futuremed Healthcare(FMD.TO)

Dec 02, 2010
Distribute healthcare products primarily to retirement homes. Started to see more competition in the 2nd quarter and intensified in the 3rd quarter. Cut distributions once but may do another cut. He’ll wait for Q4 results.
Photo of Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$6.39

Stock price when the opinion was issued

biotechnologypharmaceutical
COMMENT

Futuremed Healthcare(FMD.TO)

Aug 25, 2010
Rarely sells after an earnings disappointment. Doesn’t think there is a structural problem with the business. They need to get some clarity on how they will transition into what is in effect a new business model where they will have a growth side.
Photo of Sandy McIntyreSandy McIntyre
Owned
Unlock Rating
$8.00

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Futuremed Healthcare(FMD.TO)

Jul 07, 2010
Distributes supplies such as wound management, chairs, furniture, etc. to retirement homes. Well run. Have already cut their distributions. Trades at 6 times EBITDA.
Photo of Michael Simpson, CFAMichael Simpson, CFA
Owned
Unlock Rating
$9.20

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Futuremed Healthcare(FMD.TO)

Dec 16, 2009
Conservative name trading at 10-11 times PE. Entrepreneurial management team with ownership in the company. Strong market share in the distribution business in healthcare and long term care facilities.
Photo of Jamie HorvatJamie Horvat
Owned
Unlock Rating
$9.35

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Futuremed Healthcare(FMD.TO)

Jul 07, 2009
Distribution services for nursing homes. Generates a lot of free cash flow. Nursing homes are a growing market. Recession resistant. 13% distribution.
Photo of Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$7.31

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Futuremed Healthcare(FMD.TO)

Feb 26, 2009
Distributor of medical products, mostly in Ontario. Just bought a Quebec company, which should grow revenues and margin expansion. 12% distribution is likely to be increased this year. Earnings per share should grow at 10%-20% also.
Photo of Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$7.96

Stock price when the opinion was issued

biotechnologypharmaceutical
COMMENT

Futuremed Healthcare(FMD.TO)

May 05, 2008
Sells supplies to nursing homes, which is a growth industry long-term. Good management team.
Photo of Sandy McIntyreSandy McIntyre
No
Unlock Rating
$10.27

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Futuremed Healthcare(FMD.TO)

Jan 21, 2008
He supplied provider to hospitals, nursing homes, et cetera. Healthcare sector so very protected in the event of a recession. Growing between 5% and 15% annually. Generates a lot of free cash flow. Distribution of around $.92 giving a 10% yield plus 10% growth.
Photo of Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$9.70

Stock price when the opinion was issued

biotechnologypharmaceutical
TRADE

Futuremed Healthcare(FMD.TO)

Oct 19, 2007
It's appropriately priced. A fairly stable business. They do the distribution of medical products.
Photo of Chris Rankin, MBA, CFAChris Rankin, MBA, CFAUnlock Rating
$11.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Futuremed Healthcare(FMD.TO)

Jan 04, 2007
Provide diapers/furniture to old age care facilities. Disappointed in some of their early earnings.
Photo of Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$9.60

Stock price when the opinion was issued

biotechnologypharmaceutical
COMMENT

Futuremed Healthcare(FMD.TO)

Dec 27, 2006
Sold his holdings. Really like the company because it was health care and not cyclical. Long-term outlook is really great. Good management. Price has dropped and he expects at some time he will own it again. Will look at the next quarter’s results.
Photo of Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$9.58

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Futuremed Healthcare(FMD.TO)

Aug 11, 2006
Basically distributes products to the long care sector. A play on the ageing population. 70/75% of its business is very stable. Has performed quite well. Also sells diagnostic equipment, which tends to be volatile. Expensive at the current level.
Photo of Garth JestleyGarth Jestley
No
Unlock Rating
$12.40

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Futuremed Healthcare(FMD.TO)

Jun 05, 2006
(A Top Pick Feb 15/06. Up 30%.) A very stable business distributing supplies to retirement homes. A lot of free cash flow.
Photo of Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$13.27

Stock price when the opinion was issued

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

BTE.TO 0.11$5.71
CS.TO -0.62$14.61
SKE.TO -0.73$39.75
WHN.V 0$0.29
SII.TO -7.01$165.77

Today's Top Picks

ARK.V 0$
SGD.V 0.46$15.93
AEM.TO -4.78$231.28
MEQ.TO -1.05$168.2
TRI.TO 2.93$113.95

Popular Articles

Latest Sell Signals

DOL.TO -0.96$186.89
CTC.A.TO -0.55$186.09
CCO.TO 0.61$151.07
CAT 1.18$987
EQB.TO 1.5$126.19

Most Recent Experts

Rick Rule

Rick Rule

Rule Investment Media

Chris Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica